Nijhof, I. S., van Bueren, J. J. L., van Kessel, B., Andre, P., Morel, Y., Lokhorst, H. M., van de Donk, N. W., Parren, P. W. and Mutis, T. (2015) “Daratumumab-mediated lysis of primary multiple myeloma cells is enhanced in combination with the human anti-KIR antibody IPH2102 and lenalidomide”, Haematologica. Pavia, Italy, 100(2), pp. 263-268. doi: 10.3324/haematol.2014.117531.